CSF1R and glioblastoma: Inhibitors of the (CSF-1R) (anti-CSF1R antibody-like Cabiralizumab, SNDX-6352, BLZ945, PLX3397, etc.)to diminish the TAMs population in mouse GBM model significantly increases the survival and shrinks the established tumors [182].